LONDON, February 23, 2017 /PRNewswire/ --
PharmaBoardroom today releases its new 58-page Healthcare & Life Sciences
This report offers companies, investors, policymakers, and stakeholders crucial insight into Singapore; a nation that has had to carve out its own niche as a global trade hub and
The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on Singapore's healthcare and pharma sectors.
Featured topics include:
The report features in-depth interviews with:
"Singapore is the example of how efficiency can be improved when the government and the industry work together collaboratively"
Ti Hwei How, SAPI
"With roughly hald of the world's population here in Asia Pacific, we see an increase in unmet medical needs which will continue to grow with aging populations and the surge of chronic diseases"
Gary Pruden, J&J
"Singapore is an excellent engineering and microelectronics hub so the technology is of the best calibre here"
Michael Tillmann, Vela Diagnostics
"APAC is estimated at 25 percent of the global economy and within 10 years it is expected to grow to 35 percent."
Martin Dewhurst, McKinsey & Company
Click here to register and download the report.
Subscribe to our Free Newsletters!
Breathing in unclean air due to increasing air pollution could cause kidney damage with resultant ...
Benign prostatic hyperplasia or enlarged prostate is a noncancerous condition observed in men above ...
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...View All